Given that EGFR inhibitor-induced apoptosis in EGFR-mutant tumors is preceded by a pronounced cell cycle arrest [10], we hypothesized that imaging modalities reflecting tumor cell proliferation rather than glucose metabolism might afford even earlier measurements of tumor growth inhibition. Here, EGFR is linked to neoplasm.